Topic: Cancer Stem Cells

1 chapters across the catalog

Dr. Makis details the mechanisms by which Ivermectin, Fenbendazole, and Mebendazole combat cancer, including the targeting of cancer stem cells and reversing chemo-resistance. He notes that Johns Hopkins holds a patent on Mebendazole for brain cancer, yet the information is suppressed. The segment also covers the high excess mortality in Japan and the growing resistance among Japanese doctors.